OR

Browse by Year  All | 2009 | 2008 | 2007 | 2006

News Search Results

Found 52 news items in 2008.

Page of 3, showing news items 1-20 of 52.     Next Page
  • December 23, 2008 Winter Wonderland Dinner Raises $1.7 million for National Jewish Health New York Real Estate and Construction Industries Dinner, on December 13, 2008, raises $1.7 million for National Jewish Health.
  • December 17, 2008 Change is Coming for Asthma Inhalers Millions of asthma patients are facing a federally mandated change by the end of the year in the inhalers they use. For many, there is concern and confusion over the change and how it will affect them. The medicine in quick-relief asthma inhalers is staying the same, but the chemical used to “propel” the medicine is changing.
  • December 17, 2008 Don't Let a Relapse Sabotage Your New's Year's Resolution Behavioral change expert Heather LaChance, PhD, offers advice to help improve your chances of successfully quitting tobacco or losing weight.
  • December 11, 2008 Hypoallergenic dog? Not likely, according to National Jewish Health National Jewish Health physicians comment on hypoallergenic dogs and how to reduce allergenic effects of a dog.
  • December 11, 2008 National Jewish Physician Supports Access to Long-Acting Beta Agonists Limiting the availability of medications known as long-acting beta agonists (LABA) would set asthma care back 20 years and increase risks of more asthma attacks, neurological adverse effects, growth and adrenal suppression, osteoporosis and cataracts, according to a National Jewish Health physician
  • December 10, 2008 National Jewish Health, LabCorp to Collaborate National Jewish Health and Laboratory Corporation of America have reached an agreement to collaborate in the development and commercialization of molecular diagnostic tests in support of personalized medicine.
  • December 5, 2008 Bacteria Implicated in Steroid-Resistance Among Asthmatics A series of experiments by researchers at National Jewish Health have implicated the remains of bacterial cell walls in the development of resistance to corticosteroids.
  • December 3, 2008 31st Annual Pulmonary & Allergy Update Allergists, pulmonologists and general practitioners can learn the approaches and methods used to diagnose and treat allergic, respiratory and immune diseases.
  • December 3, 2008 31st Annual Pulmonary and Allergy Update Allergists, pulmonologists and general practitioners can learn the approaches and methods used to diagnose and treat allergic, respiratory and immune diseases.
  • November 26, 2008 National Jewish Health Recognized by El Pomar Foundation El Pomar Foundation awarded National Jewish Health the Joel A. H. Webb Award for Excellence, recognizging its service to community.
  • November 17, 2008 Gary Smith, PhD, Hired to Lead Advanced Diagnostics Laboratories With more than a decade of experience in reference laboratory leadership, Gary L. Smith, PhD, will lead the nation's premier reference laboratory for respiratory, immune and related diseases.
  • November 14, 2008 Nontuberculous Mycobacterial Disease (NTM) Deemed “Burgeoning Medical Challenge” Nontuberculous mycobacteria (NTM), little known cousins of the organism that causes tuberculosis, may cause significantly greater healthcare spending and patient suffering in the United States and Canada than does tuberculosis.
  • November 11, 2008 National Jewish Health Opens Vail Clinic National Jewish Health, through its Pediatric program NJ4kids, is bringing its world-renowned expertise in pediatric respiratory and allergic diseases to the Vail Valley.
  • October 28, 2008 National Jewish, Phadia to Collaborate National Jewish Health announced today that it has entered a co-promotion agreement with Phadia US Inc. to build recognition of the important role allergy testing plays in the diagnosis and treatment of asthma and other respiratory diseases. Under the agreement, National Jewish Health will help create educational programs, activities and literature to promote to pulmonologists the value of understanding allergy in the diagnosis and management of patients with respiratory diseases.
  • October 23, 2008 NBC News Vists National Jewish NBC Nightly News chief health and science correspondent Robert Bazell spent two full days on the National Jewish Health campus in September developing a three-part series on allergies, which ran September 29 through October 1.
  • October 22, 2008 EASE Trial to Evaluate Emphysema Treatment Researchers at National Jewish Health are testing an investigational treatment to learn if poking holes in the lungs of emphysema patients can immediately help them breathe more easily. Destruction of lung tissue caused by emphysema can leave lungs stiff and overinflated with air that cannot escape. The holes, kept open by small stents inserted during a minimally invasive procedure, could relieve the hyperinflation of the lungs, allowing the healthy parts of the lungs to more easily inflate and take in air.
  • October 13, 2008 Asthma Experts Advice Pediatricians Pediatricians need to diagnose asthma earlier and identify allergy triggers if they want to achieve better outcomes with their asthma patients, according to allergy and asthma experts who spoke at an educational program sponsored by National Jewish Health.
  • October 13, 2008 Immunologists Kappler, Marrack Elected to Institute of Medicine National Jewish Health Immunologists Phillippa Marack and John Kappler have been elected to the Institute of Medicine
  • October 6, 2008 Family Air Care Launch Home owners, buyers and renters can now assure that their indoor environment is healthy and safe with an easy-to-use kit manufactured and serviced by the nation’s number one respiratory hospital, National Jewish Health. The Family Air Care Indoor Allergens and Mold Test Kit reports levels of the most common indoor allergens and a relative moldiness index. The product will be especially useful for millions of people with allergies and asthma, who can benefit from lower exposure to allergens and irritants in their environment.
  • October 1, 2008 Steroids Not as Effective in Overweight Asthma Patients Researchers at National Jewish Health have shown that glucocorticoids, the primary controller medication for asthma, are 40 percent less effective in overweight and obese asthma patients than in those of normal weight.

Appointments

1-800-222-5864

Media Contacts

William Allstetter
Tel: 303-398-1002
Pager: 303-281-1653
E-mail: allstetterw@njc.org

Adam Dormuth
Tel: 303-398-1082
Pager: 303-851-0358
E-mail: dormutha@njc.org

News Archive

Browse by Year  All | 2009 | 2008 | 2007 | 2006